Suppr超能文献

冷冻保护剂对人碳酸酐酶II-乙酰唑胺复合物结构和热稳定性的影响。

Effects of cryoprotectants on the structure and thermostability of the human carbonic anhydrase II-acetazolamide complex.

作者信息

Aggarwal Mayank, Boone Christopher D, Kondeti Bhargav, Tu Chingkuang, Silverman David N, McKenna Robert

机构信息

Department of Biochemistry and Molecular Biology, College of Medicine, University of Florida, 1600 SW Archer Road, PO Box 100245, Gainesville, FL 32610, USA.

出版信息

Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):860-5. doi: 10.1107/S0907444913002771. Epub 2013 Apr 19.

Abstract

Protein X-ray crystallography has seen a progressive shift from data collection at cool/room temperature (277-298 K) to data collection at cryotemperature (100 K) because of its ease of crystal preparation and the lessening of the detrimental effects of radiation-induced crystal damage, with 20-25%(v/v) glycerol (GOL) being the preferred choice of cryoprotectant. Here, a case study of the effects of cryoprotectants on the kinetics of carbonic anhydrase II (CA II) and its inhibition by the clinically used inhibitor acetazolamide (AZM) is presented. Comparative studies of crystal structure, kinetics, inhibition and thermostability were performed on CA II and its complex with AZM in the presence of either GOL or sucrose. These results suggest that even though the cryoprotectant GOL was previously shown to be directly bound in the active site and to interact with AZM, it affects neither the thermostability of CA II nor the binding of AZM in the crystal structure or in solution. However, addition of GOL does affect the kinetics of CA II, presumably as it displaces the water proton-transfer network in the active site.

摘要

由于易于制备晶体以及减少辐射诱导的晶体损伤的有害影响,蛋白质X射线晶体学已逐渐从在低温/室温(277 - 298 K)下收集数据转向在低温(100 K)下收集数据,20 - 25%(v/v)的甘油(GOL)是首选的冷冻保护剂。在此,展示了一个关于冷冻保护剂对碳酸酐酶II(CA II)动力学及其被临床使用的抑制剂乙酰唑胺(AZM)抑制的影响的案例研究。在存在GOL或蔗糖的情况下,对CA II及其与AZM的复合物进行了晶体结构、动力学、抑制作用和热稳定性的比较研究。这些结果表明,尽管冷冻保护剂GOL先前已被证明直接结合在活性位点并与AZM相互作用,但它既不影响CA II的热稳定性,也不影响AZM在晶体结构或溶液中的结合。然而,添加GOL确实会影响CA II的动力学,推测是因为它取代了活性位点中的水质子转移网络。

相似文献

1
Effects of cryoprotectants on the structure and thermostability of the human carbonic anhydrase II-acetazolamide complex.
Acta Crystallogr D Biol Crystallogr. 2013 May;69(Pt 5):860-5. doi: 10.1107/S0907444913002771. Epub 2013 Apr 19.
2
High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Oct 1;65(Pt 10):992-5. doi: 10.1107/S1744309109036665. Epub 2009 Sep 25.
3
Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII.
Bioorg Med Chem Lett. 2013 Oct 15;23(20):5646-9. doi: 10.1016/j.bmcl.2013.08.019. Epub 2013 Aug 13.
4
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae.
Acta Crystallogr D Biol Crystallogr. 2015 Dec 1;71(Pt 12):2449-56. doi: 10.1107/S1399004715018635. Epub 2015 Nov 26.
6
Neutron diffraction of acetazolamide-bound human carbonic anhydrase II reveals atomic details of drug binding.
J Am Chem Soc. 2012 Sep 12;134(36):14726-9. doi: 10.1021/ja3068098. Epub 2012 Sep 4.
10
Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa.
Bioorg Med Chem. 2015 Aug 1;23(15):4831-4838. doi: 10.1016/j.bmc.2015.05.029. Epub 2015 Jun 8.

引用本文的文献

1
Hidden targets in dermatology: and inhibitory effects of common 23 dermatologic drugs on human carbonic anhydrase isoenzymes I and II.
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2540935. doi: 10.1080/14756366.2025.2540935. Epub 2025 Aug 5.
3
Structural insight into activity enhancement and inhibition of H64A carbonic anhydrase II by imidazoles.
IUCrJ. 2014 Feb 28;1(Pt 2):129-35. doi: 10.1107/S2052252514004096. eCollection 2014 Mar 1.
4
Carbonic anhydrases and their biotechnological applications.
Biomolecules. 2013 Aug 19;3(3):553-62. doi: 10.3390/biom3030553.
5
Structural, catalytic and stabilizing consequences of aromatic cluster variants in human carbonic anhydrase II.
Arch Biochem Biophys. 2013 Nov 1;539(1):31-7. doi: 10.1016/j.abb.2013.09.001. Epub 2013 Sep 10.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Structural annotation of human carbonic anhydrases.
J Enzyme Inhib Med Chem. 2013 Apr;28(2):267-77. doi: 10.3109/14756366.2012.737323. Epub 2012 Nov 9.
3
Insights towards sulfonamide drug specificity in α-carbonic anhydrases.
Bioorg Med Chem. 2013 Mar 15;21(6):1526-33. doi: 10.1016/j.bmc.2012.08.019. Epub 2012 Aug 28.
4
Neutron diffraction of acetazolamide-bound human carbonic anhydrase II reveals atomic details of drug binding.
J Am Chem Soc. 2012 Sep 12;134(36):14726-9. doi: 10.1021/ja3068098. Epub 2012 Sep 4.
5
Update on carbonic anhydrase inhibitors: a patent review (2008 - 2011).
Expert Opin Ther Pat. 2012 Aug;22(8):903-15. doi: 10.1517/13543776.2012.707646. Epub 2012 Jul 13.
6
Can radiation damage to protein crystals be reduced using small-molecule compounds?
Acta Crystallogr D Biol Crystallogr. 2011 Oct;67(Pt 10):881-93. doi: 10.1107/S0907444911032835. Epub 2011 Sep 8.
7
Accessing protein conformational ensembles using room-temperature X-ray crystallography.
Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16247-52. doi: 10.1073/pnas.1111325108. Epub 2011 Sep 14.
8
Perspectives on carbonic anhydrase.
Comp Biochem Physiol A Mol Integr Physiol. 2010 Nov;157(3):193-7. doi: 10.1016/j.cbpa.2010.06.161. Epub 2010 Jun 9.
9
De-icing: recovery of diffraction intensities in the presence of ice rings.
Acta Crystallogr D Biol Crystallogr. 2010 Jun;66(Pt 6):741-4. doi: 10.1107/S0907444910012436. Epub 2010 May 15.
10
A short, strong hydrogen bond in the active site of human carbonic anhydrase II.
Biochemistry. 2010 Jan 19;49(2):249-51. doi: 10.1021/bi902007b.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验